试验提前终止状态未知 → 提前终止
High-Dose Ambroxol in GBA1-Related Parkinson
NCT06193421 · 申办者:Agyany Pharma LTD试验地点:Israel
登记停止说明(原文):Sponsor's decision
来源:ClinicalTrials.gov(美国登记平台)来源更新:2026-11-09发现时间:2026/11/10 01:15:50推送接口已接受
试验提前终止尚未招募 → 提前终止
A Repeat Dose Study of the Dexmedetomidine Transdermal System in Healthy Subjects
NCT07818330 · 申办者:Teikoku Pharma USA, Inc.试验地点:澳大利亚
登记停止说明(原文):Sponsor decision, after observation of adverse events
来源:ClinicalTrials.gov(美国登记平台)来源更新:2026-11-09发现时间:2026/11/10 01:15:50推送接口已接受
试验入组前撤回尚未招募 → 入组前撤回
Zanzalintinib for Advanced Urothelial Carcinoma Progressing After Prior Therapy
NCT07185945 · 申办者:Guru Sonpavde试验地点:未提供
登记停止说明(原文):Funder withdrew
来源:ClinicalTrials.gov(美国登记平台)来源更新:2026-11-09发现时间:2026/11/10 01:15:50推送接口已接受
试验入组前撤回尚未招募 → 入组前撤回
Study to Evaluate Safety, Tolerability and Pharmacodynamics of KP104 in Participants With Thrombotic Microangiopathy Secondary to Systemic Lupus Erythematosus
NCT05504187 · 申办者:Kira Pharmacenticals (US), LLC.试验地点:未提供
登记停止说明(原文):Sponsor Decision - terminated due to changes in company priorities and not related to safety concerns
来源:ClinicalTrials.gov(美国登记平台)来源更新:2026-11-09发现时间:2026/11/10 01:15:50推送接口已接受
试验提前终止状态未知 → 提前终止
Efficacy of Colchicine to Prevent Skin Relapses in Adult's IgA Vasculitis
NCT04008316 · 申办者:Assistance Publique - Hôpitaux de Paris试验地点:法国
登记停止说明(原文):Sponser decision
来源:ClinicalTrials.gov(美国登记平台)来源更新:2026-11-06发现时间:2026/11/7 01:17:52推送接口已接受
试验入组前撤回招募中 → 入组前撤回
SAFE Study: Safety of aPCC Following Emicizumab Prophylaxis
NCT04563520 · 申办者:Emory University试验地点:美国
登记停止说明(原文):The study was withdrawn because the pharmaceutical sponsor withdrew support for the study. No participants were enrolled before termination.
来源:ClinicalTrials.gov(美国登记平台)来源更新:2026-11-06发现时间:2026/11/7 01:17:52推送接口已接受
试验提前终止进行中(不再招募) → 提前终止
Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 2
NCT06006143 · 申办者:Yale University试验地点:美国
登记停止说明(原文):recruitment challenges
来源:ClinicalTrials.gov(美国登记平台)来源更新:2026-11-06发现时间:2026/11/7 01:17:52推送接口已接受
试验入组前撤回尚未招募 → 入组前撤回
Phenobarbital for Agitated Delirium
NCT07548489 · 申办者:Duke University试验地点:美国
登记停止说明(原文):Not approved by IRB
来源:ClinicalTrials.gov(美国登记平台)来源更新:2026-11-06发现时间:2026/11/7 01:17:52推送接口已接受
暂停后恢复暂停 → 招募中
Glofitamab With Obinutuzumab Pre-treatment for the Treatment of Central Nervous System Lymphoma
NCT06922604 · 申办者:City of Hope Medical Center试验地点:美国
来源:ClinicalTrials.gov(美国登记平台)来源更新:2026-11-06发现时间:2026/11/7 01:17:52推送接口已接受
试验暂停招募中 → 暂停
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
NCT04318717 · 申办者:Washington University School of Medicine试验地点:美国
登记停止说明(原文):protocol amendment
来源:ClinicalTrials.gov(美国登记平台)来源更新:2026-11-06发现时间:2026/11/7 01:17:52推送接口已接受
试验入组前撤回尚未招募 → 入组前撤回
Low Dose Dexamethasone for the Prevention of Cytokine Release Syndrome Associated With Tebentafusp
NCT07803562 · 申办者:University of California, San Diego试验地点:美国
登记停止说明(原文):Lack of funding
来源:ClinicalTrials.gov(美国登记平台)来源更新:2026-11-06发现时间:2026/11/7 01:17:52推送接口已接受
试验入组前撤回暂停 → 入组前撤回
Ketamine-assisted Psychotherapy for Adolescent PTSD (KAP)
NCT06378528 · 申办者:University of Wisconsin, Madison试验地点:未提供
登记停止说明(原文):Budgeting/funding
来源:ClinicalTrials.gov(美国登记平台)来源更新:2026-11-06发现时间:2026/11/7 01:17:52推送接口已接受
试验提前终止进行中(不再招募) → 提前终止
Study of JDQ443 in Comparison With Docetaxel in Participants With Locally Advanced or Metastatic KRAS G12C Mutant Non-small Cell Lung Cancer
NCT05132075 · 申办者:Novartis Pharmaceuticals试验地点:美国、Argentina、澳大利亚等 25 个国家或地区
美国、Argentina、澳大利亚、加拿大、中国、Finland、Greece、Hong Kong、Hungary、Iceland、印度、意大利、Jordan、黎巴嫩、Malaysia、Mexico、Portugal、Romania、Slovenia、South Korea、西班牙、Taiwan、Thailand、Turkey (Türkiye)、Vietnam
登记停止说明(原文):Business reasons and not based on any safety concerns.
来源:ClinicalTrials.gov(美国登记平台)来源更新:2026-11-06发现时间:2026/11/7 01:17:52推送接口已接受
试验提前终止招募中 → 提前终止
EUS RFA for Treatment of Pancreatic Ductal Adenocarcinoma (PDAC)
NCT05723107 · 申办者:NYU Langone Health试验地点:美国
登记停止说明(原文):Halted prematurely
来源:ClinicalTrials.gov(美国登记平台)来源更新:2026-11-06发现时间:2026/11/7 01:17:52推送接口已接受
试验入组前撤回状态未知 → 入组前撤回
Efficacy of Oxfendazole in the Treatment of Trichuris Trichiura Infection in Adults
NCT03435718 · 申办者:Oxfendazole Development Group试验地点:未提供
登记停止说明(原文):Study cancelled prior to initiation as the Oxfendazole Development Group is collaborating on a similar study being conducted by AB Prisma, NCT4713787
来源:ClinicalTrials.gov(美国登记平台)来源更新:2026-11-06发现时间:2026/11/7 01:17:52推送接口已接受
试验提前终止暂停 → 提前终止
Comparison of Conjunctival Antimicrobial Activity and Patient Comfort Between Topical Hypochlorous Acid (Avenova) and Betadine
NCT04981860 · 申办者:University of Miami试验地点:美国
登记停止说明(原文):The study was terminated early due to operational feasibility challenges, including multi-site coordination and administrative barriers. The study team determined continuation was not feasible, and all study activities were discontinued.
来源:ClinicalTrials.gov(美国登记平台)来源更新:2026-11-05发现时间:2026/11/6 01:16:30推送接口已接受
试验提前终止状态未知 → 提前终止
FS120 Phase 1/1b Study in Patients With Advanced Malignancies
NCT04648202 · 申办者:invoX Pharma Limited试验地点:美国、西班牙
登记停止说明(原文):The study was terminated early due to a strategic business decision by the Sponsor, unrelated to safety.
来源:ClinicalTrials.gov(美国登记平台)来源更新:2026-11-05发现时间:2026/11/6 01:16:30推送接口已接受
试验提前终止招募中 → 提前终止
CT-95 in Advanced Cancers Associated With Mesothelin Expression
NCT06756035 · 申办者:Context Therapeutics Inc.试验地点:美国
登记停止说明(原文):The study was halted prematurely and will not resume; participants are no longer receiving intervention or undergoing evaluations. The termination was not due to any safety or efficacy concerns.
来源:ClinicalTrials.gov(美国登记平台)来源更新:2026-11-05发现时间:2026/11/6 01:16:30推送接口已接受
试验提前终止招募中 → 提前终止
Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression After a First-time Treatment Failure
NCT05603104 · 申办者:Dr. Inge Winter试验地点:Israel
登记停止说明(原文):The site in Israel stopped recruitment due to logistic reasons. Other sites are recruiting for 2023-506602-39-00, 2023-506605-19-00, 2023-506617-21-00.
来源:ClinicalTrials.gov(美国登记平台)来源更新:2026-11-05发现时间:2026/11/6 01:16:30推送接口已接受
试验提前终止暂停 → 提前终止
Evaluation of Topical Application of BMX-010 in Subjects With Rosacea
NCT03756389 · 申办者:BioMimetix JV, LLC试验地点:美国
登记停止说明(原文):Re-formulation of study product needed.
来源:ClinicalTrials.gov(美国登记平台)来源更新:2026-11-05发现时间:2026/11/6 01:16:30推送接口已接受